All Press Releases
2017, 05, 09 — PILA PHARMA has carried out a fully subscribed new issue of shares
Malmö, Sweden, 9th May 2017 PILA PHARMA has carried out a fully subscribed new issue of shares PILA PHARMA AB, a Swedish pharmaceutical company based in Malmö, is pleased to announce that the company has raised SEK 10 million through a fully subscribed new issue shares. Both existing shareholders and new investors participated in the new issue. ALMI Invest for the third time…
2017, 03, 06 — PILA PHARMA receives regulatory approval of its first clinical trial application and appoints new Chairman of the Board
Malmö, Sweden, 6th March 2017 PILA PHARMA receives regulatory approval of its first clinical trial application and appoints new Chairman of the Board PILA PHARMA AB, a Swedish pharmaceutical company based in Malmö, Sweden, is pleased to announce that it has received regulatory approval of its first clinical trial application thus permitting the company to move its clinical development candidate, XEN-D0501, into a…
2016, 06, 22 — Press release / PILA PHARMA successfully completes new shares emission and strengthens the Board of Directors
Malmö, Sweden, 22 June 2016 PILA PHARMA successfully completes new shares emission and strengthensthe Board of Directors PILA PHARMA raises new capital to initiate the clinical assessment of XEN-D0501 as novel anti-diabetic agent PILA PHARMA AB, Malmö, Sweden announced today it has completed a successful new shares emission which will allow the company to progress its newly acquired clinical development candidate,…